A halleluljah announcement just days before the AGM would imo be proof that investors in SPL have for years been treated like mugs. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. SPL Price at posting: 16. ASX - By Stock. Some paralllels with SPL, although every product and data is different, but a least MSB are pretty clear with CRL - not pretty fro shareholders and going to take a lot of funding and dillution to achieve trial that could have been completesd in that same timeframe and IMO a lower risk. ASX - By Stock. Market Cap $. SPL's current SP is about 15 cents, after many years (some say 20 years) of unprofitability, during which time substantial salaries and performance bonuses appear to have been paid. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. Provide some keywords to assist in categorisation of your abstract. 57. Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. Zeus Resources Limited is an Australia-based mineral exploration company. SPL Price at posting. Market . IMO they haven't . When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. They not even have a license with SPL, just a basic research agreement. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 1 Introduction. Created with Sketch. 0. Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. great news but unlikely. Change in substantial holding. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day Trading. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Hi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Created with Sketch. Forums. I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. Just as I thought - both @antibotter and JF & Co. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. 3¢. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. I am not up to date with all brexit stuff let alone othe rcountries like Vietnam , HK and very cautiious about consultants websites and simply govt websites area nightmare to understand and navigate unless it is your speciality. Join the HotCopper ASX share market forum today for free. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. Forums. Become the CEO of Starpharma Step 2. June 9 (Reuters) - Starpharma Holdings Ltd (SPL) : STARPHARMA CEO TO RETIRE IN 2024 FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE OFFICER. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. 74. Last updated 15. Created with Sketch. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. FORTESCUE METALS GROUP LTD. Target our investor community with our suite of Hotcopper Advertising opportunities. That's how markets work sometimes. Surely the political restraints. , page-2. SPL wasn't exactly a penny dreadful while in the ASX 300 and they will have hurt with capital raising at three times the current price. It is lengthy but well worth the time. ASX - General. 12. 409118. HotCopper has news,. Created with Sketch. DISCOVER THE BATTERY METALS REVOLUTION. ASX - Day Trading. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. Created with Sketch. ASX - Short Term Trading. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. Advertise on HotCopper. Remember that according to AZ’s own data, no patient had yet met the formal criteria of a response. 2327/7/2021 CSL $292. New Zealand Dollar. Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. Just sayin'. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. Forums. Phillip Altman is a highly-respected and well-known Australian authority on clinical trials and drug regulatory affairs with more than 40 years of experience in designing, managing and reporting of clinical trials and in working with the Australian Therapeutic Goods Administration (TGA) in gaining new drug approvals. SPL. 2:00 am Eastern Standard Time Australia. It must be great to ride the ASX executive remuneration gravy train like CEO Fairley has done for 18 years with Starpharma, and Chairman Rob Thomas has done for the majority of his long career. SPL Price at posting: 91. Advertise on HotCopper. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. Created with Sketch. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Norman Swan interviewed on ABC RN Breakfast talks about Covid Nasal vaccines and blockers. Forums. 5,006,219 was the total short sales as of 21/07/23 (1. He doesn't "hold" but 99% of his posts are on SPL, including a remarkable 350 in the last two months alone. Join the HotCopper ASX share market forum today for free. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 5. . - 12:30 p. ASX - Day TradingSo the share price of SPL rose up to a high of $2. ASX - Day TradingCreated with Sketch. 2663916. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. $1. 11%. Timeline. 56% 14. 607432. 8985. 06 Sentiment: Buy Disclosure: Held Created with Sketch. The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. 0¢ Sentiment: None Disclosure: Held LikesThe CEO seemed to exude a certain excitement in her interview with Alan Kholher have never seen her like that it was bubbling underneath every time she spoke about Viralease. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. 11%. ASX - Day TradingAnyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 9¢. ASX - By Stock. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Your missing the signals guys/gals looking too much at Viraleze, other products, CEO, BOD etc, read the signals my friend's there is a major DEP Move in. It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . My theory is we had a large accumulator that was content buying. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. Created with Sketch. 0¢. 0¢. ASX - By Stock. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. Created with Sketch. 0%. 7¢. Just begin to imagine that all staff on board use Viraleze well before. 04KBIMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Notification of cessation of securities - SPL. Forums. Market . , page-4. 0. Created with Sketch. $0. Hey, "smart", I concur with your message. Charts. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. Forex. ASX - General. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. ASX - By Stock. . However, just a word of caution before the usual pumping starts by the usual suspects. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. Share Interesting and positive early pre-clinical results. Hey, "smart", I concur with your message. Enter the title of your abstract. Latest Posts. 1. A correctly formatted example follows: Title of my presentation for the conference. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. Share Interesting points John Some institutions might accept anything over $1. Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. Commodities. $0. Forums. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. Market . 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. Eight (8) contributors to the HC SPL thread made price predictions (thank. municipal. Target our investor community with our suite of Hotcopper Advertising opportunities. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Created with Sketch. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. Add SPL (ASX) to my watchlist (20min delay). 10/10/23. . My portfolio has risen 95% since I sold SPL with conviction. Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. NEW YORK TRANSN DEV CORP SPL FAC REV 4. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. This is a charting thread for those interested in the movements of the SPL SP. . StarPharma Holdings Ltd. Their IP doesn't last forever - you need to hustle in pharma. 16,161,259. Forums. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. I saw that some director etc invested there own money in the SPP etc,. We had a Dec 2021 DCB of around the FIB 23. ASX - By Stock. StarPharma Holdings Ltd. Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. No China virus, no Flu, no colds. The bait SPL have put out about models and publishing in 3 weeks should be stopped by ASX / ASIC and teh timing is odd IMO. SPL. Created with Sketch. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. Created with Sketch. Latest Posts. 8. , Inc. . AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Forums. I recommend that everyone sees the below. 5¢. Last post 1stPrize. This product was expected to produce rivers of. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. SPL have hit road blocks with many of their products. 68. New Zealand Dollar. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. Target our investor community with our. Hope that SPL starts to deliver on its promises. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Above $20m revenue, SPL rakes in zero R&D tax refunds until revenue becomes high enough for SPL to actually make a profit. 615, today the share price rose by 0. rights. 5¢. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. SPL always has tantalising carrots to dangle before the eyes of investors. Created with Sketch. 63. The lab that is. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day Trading So the share price of SPL rose up to a high of $2. Created with Sketch. Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. Model # 407730 Store SKU # 1000846365. And he still is Chairman or Director of SIX other companies. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. 75802. Latest Posts. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Canadian Dollar. ASX - By Stock Forum | Join the HotCopper forum today for free. 4. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Join the HotCopper ASX share market forum today for free. my apologies that I could not stay after the. ASX - Day TradingSPL buy back distribution agreement , LLoyds hand it back or SPL formally takes action for the agreement to be cancelled due to a default in obligations. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. The ASX is trying to crack down on many companies. Furthermore the shameful and disappointing thing is that some pumpers on this forum were encouraging newbies (even when the SP hit its $2. Created with Sketch. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. Charts. Last updated 15. Hey, "smart", I concur with your message. . Views. 5. ASX - Day Trading. $0. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. ASX - By Stock. I sold out of my position in SPL at that time precisely because of this. Overview. Market Cap $5. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. 00%. Add SPL (ASX) to my watchlist (20min delay). . I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. Starpharma is listed on the Australian stock exchange (ASX:SPL). 70. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. . 0¢. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Share Interesting and positive early pre-clinical results. Market . opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. The news flow coming from SPL of latehas been lackluster at best. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial upfront payment then a CR will definately be on the cards. However, I think that maybe SPL is occasionally worth a swing trade gamble. Latest Posts. Last post JoeSalami. I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). It was fairly obvious to the market that a crap raise was coming, and the SP might rise on this last chance in a while being out of the way before SPL is well capitalised. ASX - Short Term Trading. 0 Created with. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. Twenty years later it’s 84. 88. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Join the HotCopper ASX share market forum today for free. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. In part it oversees accelerated research initiatives to develop responses to unmet needs. Views. Created with Sketch. 138. . SPL scientists will no doubt be working on this right now. Charts. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. However, just a word of caution before the usual pumping starts by the usual suspects. 5¢. ACCELERATE RESOURCES LIMITED. The matter has been adjourned to. LEADING THE BATTERY METALS REVOLUTION. Application for quotation of securities - SPL. 63M. Join the HotCopper ASX share market forum today for free. ASX - By Stock. SPL is tanking, HQ are overpromising and under delivering. 0. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. 0. Additionally, three of the companies mentioned that have approved and marketed IO. 1029/9/2000 SPL $0. ASX - By Stock. . Join the HotCopper ASX share. ASX - By Stock. HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. Created with Sketch. The goal of the partnership. ASX - By Stock. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. You not understand how clinical trials works - it takes years to build regulatory packanage and do CMC. 4¢. See All Discussions. CEO knows it is all going. yet if one considers that the amount of millions of shares via option they. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. I am closely watching the state of the World Economy, particularly China and the U. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. . Application for quotation of securities - SPL. NSX - By Stock. ASX - Day TradingMelbourne, Australia; 8 December 2022: Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announces that it has commenced recruitment in the UK for a post- market clinical study of its broad-spectrum antiviral barrier nasal spray, VIRALEZETM, in patients with COVID-19, following receipt of the necessary regulatory and ethics. Talk with one of our capital. . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Forums. Market. MGU Magnum Mining and Exploration piecing together optimal logistics plan for Buena Vista iron ore projectI don’t hold, but depending on timing with other investments and Starpharma developments I may become a SPL holder again if the SP drops another 10-20%. Join the HotCopper ASX share market forum today for free. 5¢. No change of interest notification received. The last time was December 2018. 48. Eight (8) contributors to the HC SPL thread made price predictions (thank. Enter the title of your abstract. 3. Created with Sketch. Hotcopper has reinvented itself as The Market Herald with an ASX code of TMH The company has an online news site called The Market Herald Below is a. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. 375% 0. ROFL. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. 03% or subsequently a decrease in shorts of. . 70% 14. . Latest Posts. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. Advertise on HotCopper. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions. Last updated 15. . 45K. In summary, there appears to be a massive financial incentive ($7m per year) for SPL to keep turnover below $20m, until such time as sufficient progress has been made on all fronts for profitability to become a. 199920. Created with Sketch. Shouldn’t company have announced departure of key person when. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. SPL Price at posting: 14. Some links within this article worth a scan too. Thanks for all your hard work and many successes during the year. 2:00 am Eastern Standard Time Australia. IMO maybe you positive posters should just take a breather for a little while and wait until the tide turns and this company shows some signs of life?Sept 28 (Reuters) - Starpharma Holdings Ltd (SPL) : REQUESTS FOR A TRADING HALT PENDING AN ANNOUNCEMENT TO MARKET REGARDING A PROPOSED EQUITY CAPITAL. Advertise on HotCopper. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. 0¢. Last updated 10. SPL need to show and reassure them that AZD0466 was cancelled not because of the dendrimer technology.